EDITION: 16 JANUARY 2020
The online magazine of Global Biodefense
Editor: Stephanie Lizotte
In This Edition
“To contain a naturally occurring outbreak, a lab accident, or a bioterrorist attack, the first response has to be the health system that identifies the pathogen, does the surveillance, finds its origin, and promotes measures to limit its damage. We must expand and sustain funding for the GHSA, the world’s vehicle for building resilient public health infrastructure.”Ambassador Jimmy Kolker, U.S. Department of Health and Human Services (former)
Source: Ending the Cycle of Crisis and Complacency in U.S. Global Health Security – A Report of the CSIS Commission on Strengthening America’s Health Security
Join us for the latest in high consequence pathogen research
Learn more + register for ASM Biothreats 2020
Biosecurity + Biodefense Jobs
Joint Civil & DoD CBRN Symposium
18-19 MARCH 2020
- Driving Medical Countermeasures Development to Limit the Adverse Health Effects of CBRN Incidents
- Modernizing Capabilities for Rapid and Accurate Threat Detection + Assessment
- Supporting Enhanced Warfighter and Emergency Personnel Protection
→ A Novel Coronavirus Challenges China by Saskia Popescu, PhD at Contagion
→ Chinese Scientists Obtain Genetic Sequence of Mysterious Virus, a Key Step in Containment Efforts by Helen Branswell at STAT
→ Just in Time for Lunar New Year, Another SARS-like Epidemic Is Brewing in China by Laurie Garrett at Foreign Policy
→ Ricin – A Bad Seed from This Podcast Will Kill You
→ This Little Virus Went to the Market – TWiV provides updates on the new coronavirus causing respiratory disease in China, the current influenza season, and the epidemic of African swine fever, including determination of the three-dimensional structure of the virus particle.
Jan 14-15: NIST Meeting on UV Disinfection Technologies and HAIs
NIST is co-hosting a 2-day meeting 14-15 Jan 2020 with the International Ultra Violet Association (IUVA) focused on examining measurement, standards, technology and data research needs to promote innovation in the effective use and implementation of ultraviolet-C (UVC) technology in healthcare settings. Learn more.
Jan 23: National Science Advisory Board for Biosecurity (NSABB) Meeting
The National Science Advisory Board for Biosecurity (NSABB) will convene 23-24 January 2020 in Bethesda, Md. The meeting will be open to the public, with attendance limited to space available. The meeting will also be videocast. January 23: 12:30 PM – 5 PM Eastern January 24: 9 AM – 2:30 PM Eastern. Learn more.
Jan 28-29: Tick-Borne Disease Working Group (TBDWG) Meeting
The 11th meeting of the Tick-borne Disease Working Group (TBDWG) will be held in Washington D.C. and by webcast. Established by Congress in 2016 as part of the 21st Century Cures Act, TBDWG provides subject matter expertise for review of federal efforts related to all tick-borne diseases, helping to improve interagency coordination and minimize overlap. Learn more
Jan 28-30: ASM Biothreats 2020 Conference
The leading annual conference on biodefense, biosecurity and biological threats, ASM Biothreats, will be held January 28–30, 2020 in Arlington, Virginia. Register now!
Feb 3: Advancing EUA IVD Products Toward Full Marketing Status
The Medical Device Innovation Consortium (MDIC) will host a workshop on 3 Feb 2020 at the FDA White Oak campus to explore key considerations for using real world data to help support in vitro diagnostic (IVD) products available under emergency use authorization (EUA) to advance to full marketing status. Learn more
Feb 25-26: Developing MCMs to Treat Acute and Chronic Effects of Ocular Chemical Toxicity
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. Learn more
Mar 3-5: Mitigating the Impact of Blast-related Burn Injuries: From Prolonged Field Care to Rehabilitation and Resilience
The 9th DoD State-of-the-Science Meeting on Blast Injury Research will be held March 3-5, 2020 in Arlington. The meeting will address epidemiology and outcomes of blast-related burn injuries; prevention and acute management of blast-related burn injuries; prolonged field care and chronic care; and transforming research. Learn more REGISTRATION IS FULL
Mar 18-19: Joint Civil & DoD CBRN Symposium
An annual gathering of the most respected minds in the CBRN defense community, including operational leaders, intelligence providers, key policymakers and solution providers from Industry and Academia. Register now
Mar 26-30: Decennial 2020 – International Conference on Healthcare Associated Infections
Held once every ten years, the Decennial Conference reviews the advances of the previous decade and the opportunities and trends for the fields of healthcare epidemiology, infectious diseases, and infection prevention and control for the future. Learn more
Mar 31-Apr 3: Preparedness Summit 2020
The NACCHO will host this year’s 2020 Preparedness Summit from 31 March – 3 April 2020 in Dallas, Texas.
Apr 20-24: Achieving Data Quality and Integrity in Maximum Containment Laboratories Training Event
This BSL-4 training event 20-24 April is co-sponsored by the FDA and UTMB Galveston National Lab. Learn more.
Jan 16: Abstracts Deadline NACCHO 360
The National Association for County and City Health Officials (NACCHO) will host their annual conference July 7–9, 2020, in Denver, Colorado. Abstracts must be submitted by January 16 at 11:59 pm (EST). Learn more.
Jan 17: Public Comments Due: Tick-Borne Disease Working Group (TBDWG) Meeting
The public will have an opportunity to present their views to the Working Group during the meeting’s public comment session or by submitting their views in writing. Learn more.
Jan 31: Registration Deadline: Developing MCMs to Treat Acute and Chronic Effects of Ocular Chemical Toxicity
Trans-Agency Scientific Meeting Feb 25-26 sponsored by the NIH Chemical Countermeasures Research Program (CCRP) in collaboration with the National Eye Institute (HHS/NIH/NEI) and U.S. Army Medical Research Institute for Chemical Defense (DoD/USAMRICD). Learn more.
Feb 20: Deadline – DARPA Personalized Protective Biosystem (PPB) *
The PPB program will develop an integrated ensemble that simultaneously reduces protective equipment needs while increasing protection for the individual against existing and future chemical and biological (CB) threats. The capability to provide unburdened CB protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing a second layer of protection, at the tissue barrier, with bio-molecular, commensal organisms, or other technologies that protect the skin, eyes, and airway from CB threats. PPB will improve mission execution by solving the current (“state of the art”) protective equipment limitations, including threat-specific vulnerabilities, thermal/logistical burdens, exposure risks during equipment removal/decontamination, and on-demand availability during unexpected threat situations. Notice ID HR001120S0015
Feb 20: Deadline – DARPA Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) *
To provide game-changing capabilities to our warfighters, DARPA must have the tools to operate at the pace of innovation. In order to capitalize on small business innovation, DARPA is piloting a new approach to advertise SBIR and STTR funding opportunities on a “just-in-time” basis, outside of the three pre-determined announcements issued at the DoD level. SBIR and STTR Opportunities (SBOs) will be announced under this BAA. Only proposals submitted in response to an active corresponding SBO will be evaluated for funding. Notice ID: HR001119S0035
Feb 25: Deadline – DARPA BTO Detect It With Gene Editing Technologies (DIGET)
The goal of the DIGET program is to leverage advances in gene editing technologies to develop low-cost, high-trust, sensitive, multiplexed, rapidly reconfigurable, and fieldable diagnostics and biosurveillance technologies to address the need for timely and comprehensive threat detection surveillance to support Department of Defense (DoD) stabilization missions and outpace infectious disease. Notice ID: HR001120S0016
Feb 28: Registration Closes for Achieving Data Quality and Integrity in Maximum Containment Laboratories Training Event
Registration closes today for BSL-4 Training: Achieving Data Quality and Integrity in Maximum Containment Laboratories taking place April 20-24, 2020 in Bethesda, MD
Apr 6: Registration Opens for Training Event: Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens in BSL-4
This no-fee course in late July 2020 is sponsored by the FDA and UTMB Galveston National Laboratory and hosted at the National Ebola Training and Education Center in Omaha. Learn more.
Sign up to receive weekly insights from the team at Global Biodefense.